Donald L. Hagan LLC’s LianBio American Depositary Shares LIAN Stock Holding History

Donald L. Hagan LLC’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,600	Closed	-$92.1K	–	109
2023 Q4	$92.1K	Buy	20,600 +5,600	+37%	+$19.3K	0.05%	98
2023 Q3	$22.4K	Hold	15,000	–	–	0.01%	91
2023 Q2	$34.2K	Buy	+15,000	New	+$34.5K	0.02%	94

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Donald L. Hagan LLC's LIAN Position: Q1 2024 in Review

Donald L. Hagan LLC sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 20,600 shares — an estimated $92.1K sold.

Donald L. Hagan LLC first reported a position in LIAN in Q2 2023 and held it in 3 quarters. The position peaked at $92.1K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Donald L. Hagan LLC reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Donald L. Hagan LLC sold 20,600 LianBio American Depositary Shares shares in Q1 2024, an estimated $92.1K.
Donald L. Hagan LLC first reported a position in LianBio American Depositary Shares in Q2 2023 and held it in 3 quarters.
Donald L. Hagan LLC's LianBio American Depositary Shares position peaked at $92.1K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Donald L. Hagan LLC's 13F filing for Q1 2024, filed 19 Apr 2024.